History and Discovery of BacteriophagesBacteriophages or phages for short were discovered in the early 20th century by British bacteriologist Frederick Twort and French-Canadian microbiologist Félix d'Herelle. Twort was the first to report on the existence of viruses that infect and kill bacteria in 1915. However, it was d'Herelle who further investigated these viruses and coined the...
The global Bacteriophage Therapy Market is estimated to be valued at US$1,148.6 million in 2020 and is expected to exhibit a CAGR of 3.7% over the forecast period 2020-2030.
A) Market Overview:
Bacteriophage therapy involves the use of bacteriophages, which are viruses that specifically target and kill bacteria. These phages can be used to treat various bacterial infections, including those...
The future of the bacteriophage therapy market holds immense potential, with opportunities for further advancements and expanded applications. In this report-oriented blog, we will discuss the future perspectives and market outlook for bacteriophage therapy.
Combination Therapies: The synergistic effects of combining bacteriophage therapy with conventional antibiotics or other treatment...
Clostridium difficile, commonly referred to as C. difficile, is a bacterium that can cause symptoms ranging from diarrhea to life-threatening inflammation of the colon. The incidence of C. difficile infection has been on the rise in recent years, posing significant challenges to healthcare providers worldwide. The diagnosis and treatment of C. difficile infections present a complex puzzle for...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian